Bio-Techne Corporation
TECHLast close · Oct 16, 202672.57+0.05 (+0.07%)
Market cap$11.4B
Between Aug 15, 2026 and Sep 28, 2026, Bio-Techne (TECH) insiders filed 40 Form 4 transactions: no sale and no open-market purchase. 40 other filings were grants, exercises or gifts, which say nothing about buying or selling.
40
0
0
0
Form 4 transactions
| Date | Insider | Title | Code | Plan | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | HIGGINS JOHN L | Director | M | 15,940 | 0.00 | $0 | |
| 2026-09-28 | HIGGINS JOHN L | Director | F | 5,562 | 72.51 | $403,300.6 | |
| 2026-09-28 | HIGGINS JOHN L | Director | M | 15,940 | 0.00 | $0 | |
| 2026-09-22 | BAUMGARTNER ROBERT V | Director | M | 15,940 | 0.00 | $0 | |
| 2026-09-22 | BAUMGARTNER ROBERT V | Director | F | 5,559 | 72.55 | $403,305.5 | |
| 2026-09-22 | BAUMGARTNER ROBERT V | Director | M | 15,940 | 0.00 | $0 | |
| 2026-08-17 | Bohnen Shane | SVP - General Counsel | A | 11,344 | 0.00 | $0 | |
| 2026-08-17 | Bohnen Shane | SVP - General Counsel | A | 18,432 | 0.00 | $0 | |
| 2026-08-17 | Kelderman Kim | Chief Executive Officer | A | 57,590 | 0.00 | $0 | |
| 2026-08-17 | Kelderman Kim | Chief Executive Officer | A | 93,582 | 0.00 | $0 | |
| 2026-08-17 | Hippel James | CFO | A | 22,438 | 0.00 | $0 | |
| 2026-08-17 | Hippel James | CFO | A | 36,459 | 0.00 | $0 | |
| 2026-08-17 | Herr Amy E. | Director | A | 1,381 | 0.00 | $0 | |
| 2026-08-17 | Geist William | PRESIDENT, PROTEIN SCIENCES | A | 14,762 | 0.00 | $0 | |
| 2026-08-17 | Geist William | PRESIDENT, PROTEIN SCIENCES | A | 23,985 | 0.00 | $0 | |
| 2026-08-17 | Crouse Steven C. | President - Diag & Spatial Bi | A | 8,702 | 0.00 | $0 | |
| 2026-08-17 | Crouse Steven C. | President - Diag & Spatial Bi | A | 14,140 | 0.00 | $0 | |
| 2026-08-15 | Kelderman Kim | Chief Executive Officer | M | 21,470 | 0.00 | $0 | |
| 2026-08-15 | Kelderman Kim | Chief Executive Officer | F | 10,821 | 72.40 | $783,440.4 | |
| 2026-08-15 | Kelderman Kim | Chief Executive Officer | M | 554 | 0.00 | $0 | |
| 2026-08-15 | Kelderman Kim | Chief Executive Officer | D | 8,319 | 0.00 | $0 | |
| 2026-08-15 | Kelderman Kim | Chief Executive Officer | D | 22,389 | 0.00 | $0 | |
| 2026-08-15 | Kelderman Kim | Chief Executive Officer | M | 588 | 0.00 | $0 | |
| 2026-08-15 | Kelderman Kim | Chief Executive Officer | D | 8,835 | 0.00 | $0 | |
| 2026-08-15 | Kelderman Kim | Chief Executive Officer | D | 24,324 | 0.00 | $0 | |
| 2026-08-15 | Kelderman Kim | Chief Executive Officer | M | 8,543 | 0.00 | $0 | |
| 2026-08-15 | Kelderman Kim | Chief Executive Officer | M | 11,785 | 0.00 | $0 | |
| 2026-08-15 | Hippel James | CFO | M | 9,779 | 0.00 | $0 | |
| 2026-08-15 | Hippel James | CFO | F | 4,310 | 72.40 | $312,044 | |
| 2026-08-15 | Hippel James | CFO | M | 866 | 0.00 | $0 | |
| 2026-08-15 | Hippel James | CFO | D | 12,999 | 0.00 | $0 | |
| 2026-08-15 | Hippel James | CFO | D | 34,982 | 0.00 | $0 | |
| 2026-08-15 | Hippel James | CFO | M | 4,010 | 0.00 | $0 | |
| 2026-08-15 | Hippel James | CFO | M | 4,903 | 0.00 | $0 | |
| 2026-08-15 | Geist William | PRESIDENT, PROTEIN SCIENCES | M | 6,416 | 0.00 | $0 | |
| 2026-08-15 | Geist William | PRESIDENT, PROTEIN SCIENCES | F | 1,976 | 72.40 | $143,062.4 | |
| 2026-08-15 | Geist William | PRESIDENT, PROTEIN SCIENCES | M | 567 | 0.00 | $0 | |
| 2026-08-15 | Geist William | PRESIDENT, PROTEIN SCIENCES | D | 8,507 | 0.00 | $0 | |
| 2026-08-15 | Geist William | PRESIDENT, PROTEIN SCIENCES | D | 22,898 | 0.00 | $0 | |
| 2026-08-15 | Geist William | PRESIDENT, PROTEIN SCIENCES | M | 2,623 | 0.00 | $0 |
Codes are the SEC's: P open-market purchase, S open-market sale; M exercise, F tax withholding, A grant and G gift are routine. A 10b5-1 flag means the trade ran under a plan adopted in advance. Method notes in where the numbers come from.